Production (Stage)
Sanara MedTech Inc.
SMTI
$29.00
-$0.31-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -133.72% | -124.59% | -2.33% | 23.50% | 18.32% |
| Total Depreciation and Amortization | 10.84% | 20.17% | 29.90% | 33.99% | 35.78% |
| Total Amortization of Deferred Charges | 3,101.20% | 3,928.85% | 7,200.00% | -- | -- |
| Total Other Non-Cash Items | 433.34% | 802.48% | 0.28% | -2.27% | 206.61% |
| Change in Net Operating Assets | 63.61% | 72.20% | 11.53% | -6.62% | -354.11% |
| Cash from Operations | 86.18% | 99.27% | 40.69% | 51.46% | 40.22% |
| Capital Expenditure | -514.14% | 22.36% | 28.87% | -226.97% | -133.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | 100.00% | -295.17% | -295.17% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.44% | 35.23% | 37.93% | -781.62% | -215.81% |
| Total Debt Issued | 327.38% | 202.83% | 202.83% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -62.49% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -70.78% | -131.89% | 9.51% | -2.75% | 18.55% |
| Cash from Financing | 237.74% | 80.13% | 93.03% | 4,320.37% | 2,173.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.60% | 381.52% | 347.96% | 101.36% | 49.66% |